Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A synthetic chemotherapeutic antibiotic of the fluoroquinolone class.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word prulifloxacin.

Examples

  • Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ prulifloxacin.

    Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent - Yahoo! Finance 2011

  • Optimer has two anti-infective product candidates under development, fidaxomicin and Pruvel™ (prulifloxacin).

    Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA - Yahoo! Finance 2010

  • Pruvel (prulifloxacin) is an antibiotic which has completed two Phase 3 clinical trials for the treatment of infectious diarrhea in travelers.

    DWS Full News Feed 2010

  • Pruvel ™ (prulifloxacin) is an antibiotic which has completed two Phase 3 clinical trials for the treatment of infectious diarrhea in travelers.

    BioSpace.com Featured News and Stories 2010

  • The decrease of $10.5 million was due primarily to 2007 expense related to a $20.0 million payment to Par Pharmaceutical Inc. to regain the rights to fidaxomicin in North America, and was partially offset by an increase in expenses related to fidaxomicin and prulifloxacin Phase 3 clinical trials in 2008.

    unknown title 2009

  • Median TLUS for patients treated with prulifloxacin in the first trial was 24.0 hours and 32.8 hours in the second trial.

    unknown title 2009

  • Announced positive results from both pivotal Phase 3 trials of prulifloxacin for the treatment of infectious diarrhea.

    GEN News Highlights 2009

  • Announced positive results from both pivotal Phase 3 trials of prulifloxacin for the treatment of infectious diarrhea.

    unknown title 2009

  • Statements included in this press release that are not a description of historical facts are forward-looking statements, including without limitation all statements related to the development of fidaxomicin and prulifloxacin, anticipated uses of cash, cash equivalents and short term investments, the timing of clinical trials and anticipated results and regulatory submissions, and potential partnering activities.

    GEN News Highlights 2009

  • Median TLUS for patients treated with prulifloxacin in the first trial was 24.0 hours and 32.8 hours in the second trial.

    GEN News Highlights 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.